EP0005129A1 — Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
Assigned to Hassle AB · Expires 1979-10-31 · 47y expired
What this patent protects
The present invention relates to novel compounds of the formula wherein R' and R 2 are same or different and are each hydrogen, alkyl, halogen, carbomethoxy, carbethoxy, alkoxy, or alkanoyl, R 6 is hydrogen, methyl or ethyl, R 3 , R 4 and R 5 are same or different and ar…
USPTO Abstract
The present invention relates to novel compounds of the formula wherein R' and R 2 are same or different and are each hydrogen, alkyl, halogen, carbomethoxy, carbethoxy, alkoxy, or alkanoyl, R 6 is hydrogen, methyl or ethyl, R 3 , R 4 and R 5 are same or different and are each hydrogen, methyl, methoxy, ethoxy, methoxyethoxy or ethoxyethoxy whereby R 3 , R 4 and R 5 are not all hydrogen, and whereby when two of R 3 , R 4 and R 5 are hydrogen the third of R 3 , R 4 and R 5 is not methyl. The compounds are potent gastric acid secretion inhibitors.
Drugs covered by this patent
- Prilosec (omeprazole) · AstraZeneca (originally Astra AB)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.